Other studies have demonstrated that sPD-1 and sPD-L1 inhibit the PD-1/PD-L1 pathway and enhance the activity of T cells, which might benefit the early treatment of multiple diseases such as autoimmune hepatitis and childhood autoimmune arthritis12,39,40. The gene discussed is CD274; the disease is autoimmune hepatitis.